Laddar...
Antidiabetic and vasoprotective activity of lithium: Role of glycogen synthase kinase-3
OBJECTIVES: Lithium is a drug of choice in maniac disorder. Lithium inhibits the glycogen synthase kinase-3 (GSK-3), an enzyme involved in the insulin signalling pathway. Elevated levels of GSK-3 were found in diabetic rats and humans. We aimed to determine the effect of lithium chloride in diabetes...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Medknow Publications
2011
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3153708/ https://ncbi.nlm.nih.gov/pubmed/21845000 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.83116 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|